Diagnostic Value, Prognostic Value, and Immune Infiltration of Family Members in Liver Cancer: Bioinformatic Analysis.
Author
Sun, ChenyuMa, Shaodi
Chen, Yue
Kim, Na Hyun
Kailas, Sujatha
Wang, Yichen
Gu, Wenchao
Chen, Yisheng
Tuason, John Pocholo W
Bhan, Chandur
Manem, Nikitha
Huang, Yuting
Cheng, Ce
Zhou, Zhen
Zhou, Qin
Zhu, Yanzhe
Date
2022-03-04Journal
Frontiers in OncologyPublisher
Frontiers Media S.A.Type
Article
Metadata
Show full item recordAbstract
Liver cancer (LC) is well known for its prevalence as well as its poor prognosis. The aberrant expression of lysyl oxidase (LOX) family is associated with liver cancer, but their function and prognostic value in LC remain largely unclear. This study aimed to explore the function and prognostic value of LOX family in LC through bioinformatics analysis and meta-analysis.Rights/Terms
Copyright © 2022 Sun, Ma, Chen, Kim, Kailas, Wang, Gu, Chen, Tuason, Bhan, Manem, Huang, Cheng, Zhou, Zhou and Zhu.Keyword
bioinformatic analysisimmune infiltration
liver cancer
lysyl oxidase
nomogram
prognostic value
receiver operating curve
Identifier to cite or link to this item
http://hdl.handle.net/10713/18350ae974a485f413a2113503eed53cd6c53
10.3389/fonc.2022.843880
Scopus Count
Collections
Related articles
- Comprehensive Analysis on Prognosis and Immune Infiltration of Lysyl Oxidase Family Members in Pancreatic Adenocarcinoma With Experimental Verification.
- Authors: Jiang C, Wang M, Yao W, Lv G, Liu X, Wang G
- Issue date: 2022
- The prognostic value of the lysyl oxidase family in ovarian cancer.
- Authors: Ye M, Zhou J, Gao Y, Pan S, Zhu X
- Issue date: 2020 Dec
- Systematic Analysis of Expression and Prognostic Values of Lysyl Oxidase Family in Gastric Cancer.
- Authors: Wang L, Cao S, Zhai R, Zhao Y, Song G
- Issue date: 2021
- Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis.
- Authors: Chen W, Yang A, Jia J, Popov YV, Schuppan D, You H
- Issue date: 2020 Aug
- <i>MIR29A</i> Impedes Metastatic Behaviors in Hepatocellular Carcinoma via Targeting <i>LOX</i>, <i>LOXL2</i>, and <i>VEGFA</i>.
- Authors: Yang YL, Tsai MC, Chang YH, Wang CC, Chu PY, Lin HY, Huang YH
- Issue date: 2021 Jun 1